Literature DB >> 28152174

Depression Case Finding in Individuals with Dementia: A Systematic Review and Meta-Analysis.

Zahra S Goodarzi1,2, Bria S Mele3, Derek J Roberts1,4,5, Jayna Holroyd-Leduc1,2.   

Abstract

OBJECTIVES: To compare the diagnostic accuracy of depression case finding tools with a criterion standard in the outpatient setting among adults with dementia.
DESIGN: Systematic review and meta-analysis.
SETTING: Studies of older outpatients with dementia. PARTICIPANTS: Elderly outpatients (clinic and long-term care) with dementia (N = 3,035). MEASUREMENTS: Prevalence of major depression and diagnostic accuracy measures including sensitivity, specificity, and likelihood ratios.
RESULTS: From the 11,539 citations, 20 studies were included for qualitative synthesis and 15 for a meta-analysis. Tools included were the Montgomery Åsberg Depression Rating Scale, Cornell Scale for Depression in Dementia (CSDD), Geriatric Depression Scale (GDS), Center for Epidemiologic Studies Depression Scale (CES-D), Hamilton Depression Rating Scale (HDRS), Single Question, Nijmegen Observer-Rated Depression Scale, and Even Briefer Assessment Scale-Depression. The pooled prevalence of depression in individuals with dementia was 30.3% (95% CI = 22.1-38.5). The average age was 75.2 (95% CI = 71.7-78.7), and mean Mini-Mental State Examination scores ranged from 11.2 to 24. The diagnostic accuracy of the individual tools was pooled for the best-reported cutoffs and for each cutoff, if available. The CSDD had a sensitivity of 0.84 (95% CI = 0.73-0.91) and a specificity of 0.80 (95% CI = 0.65-0.90), the 30-item GDS (GDS-30) had a sensitivity of 0.62 (95% CI = 0.45-0.76) and a specificity 0.81 (95% CI = 0.75-0.85), and the HDRS had a sensitivity of 0.86 (95% CI = 0.63-0.96) and a specificity of 0.84 (95% CI = 0.76-0.90). Summary statistics for all tools across best-reported cutoffs had significant heterogeneity.
CONCLUSION: There are many validated tools for the detection of depression in individuals with dementia. Tools that incorporate a physician interview with patient and collateral histories, the CSDD and HDRS, have higher sensitivities, which would ensure fewer false-negatives.
© 2017, Copyright the Authors Journal compilation © 2017, The American Geriatrics Society.

Entities:  

Keywords:  dementia; depression; detection; diagnostic test accuracy

Mesh:

Year:  2017        PMID: 28152174     DOI: 10.1111/jgs.14713

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  9 in total

Review 1.  A practical approach to detection and treatment of depression in Parkinson disease and dementia.

Authors:  Zahra Goodarzi; Zahinoor Ismail
Journal:  Neurol Clin Pract       Date:  2017-04

Review 2.  Remote cognitive and behavioral assessment: Report of the Alzheimer Society of Canada Task Force on dementia care best practices for COVID-19.

Authors:  Maiya R Geddes; Megan E O'Connell; John D Fisk; Serge Gauthier; Richard Camicioli; Zahinoor Ismail
Journal:  Alzheimers Dement (Amst)       Date:  2020-09-22

3.  The course of depressive symptoms with decline in cognitive function - a longitudinal study of older adults receiving in-home care at baseline.

Authors:  Anne-Sofie Helvik; Maria Lage Barca; Sverre Bergh; Jūratė Šaltytė-Benth; Øyvind Kirkevold; Tom Borza
Journal:  BMC Geriatr       Date:  2019-08-23       Impact factor: 3.921

4.  Comparative efficacy of interventions for reducing symptoms of depression in people with dementia: systematic review and network meta-analysis.

Authors:  Jennifer A Watt; Zahra Goodarzi; Areti Angeliki Veroniki; Vera Nincic; Paul A Khan; Marco Ghassemi; Yonda Lai; Victoria Treister; Yuan Thompson; Raphael Schneider; Andrea C Tricco; Sharon E Straus
Journal:  BMJ       Date:  2021-03-24

5.  Concordance of self- and informant-rated depressive symptoms in nursing home residents with Dementia: cross-sectional findings.

Authors:  Julie L O'Sullivan; Roxana Schweighart; Sonia Lech; Eva-Marie Kessler; Christina Tegeler; Andrea Teti; Johanna Nordheim; Paul Gellert
Journal:  BMC Psychiatry       Date:  2022-04-05       Impact factor: 3.630

Review 6.  The Relationship Between 5-Hydroxytryptamine and Its Metabolite Changes With Post-stroke Depression.

Authors:  Simeng Gu; Zhengming He; Qiuyue Xu; Jie Dong; Tingwei Xiao; Fei Liang; Xianjun Ma; Fushun Wang; Jason H Huang
Journal:  Front Psychiatry       Date:  2022-04-26       Impact factor: 5.435

7.  Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM).

Authors:  Ane Erdal; Elisabeth Flo; Dag Aarsland; Clive Ballard; Dagrun D Slettebo; Bettina S Husebo
Journal:  Drugs Aging       Date:  2018-06       Impact factor: 3.923

8.  Increasing prevalence of anticholinergic medication use in older people in England over 20 years: cognitive function and ageing study I and II.

Authors:  Carlota M Grossi; Kathryn Richardson; George M Savva; Chris Fox; Antony Arthur; Yoon K Loke; Nicholas Steel; Carol Brayne; Fiona E Matthews; Louise Robinson; Phyo K Myint; Ian D Maidment
Journal:  BMC Geriatr       Date:  2020-07-31       Impact factor: 3.921

9.  Depressive symptoms in long term care facilities in Western Canada: a cross sectional study.

Authors:  Matthias Hoben; Abigail Heninger; Jayna Holroyd-Leduc; Jennifer Knopp-Sihota; Carole Estabrooks; Zahra Goodarzi
Journal:  BMC Geriatr       Date:  2019-12-02       Impact factor: 3.921

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.